DURHAM, N.C. -- Pfizer’s COVID-19 vaccine was granted an emergency use authorization for 12- to 15-year-olds by the U.S. Food & Drug Administration on Monday.
Dr. Michael Smith, a Duke University pediatrician and infectious disease specialist involved in the pediatric trials of the Pfizer COVID-19 vaccine, discussed vaccination of adolescents during a video conference call for the media on Tuesday.
Watch the briefing on YouTube.
Quotes: